Patents by Inventor Charles Henry Rodeck

Charles Henry Rodeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of VEGF in the Treatment of Retarded Fetal Growth in Pregnancy
    Publication number: 20140121160
    Abstract: An agonist of the VEGF receptor is useful in the treatment of a disease associated with retarded fetal growth, such as intra-uterine growth retardation. The VEGF against may be a VEGF peptide or a gene construct encoding or expressing such a PI-peptide.
    Type: Application
    Filed: October 29, 2012
    Publication date: May 1, 2014
    Inventors: John Francis MARTIN, Charles Henry RODECK
  • Use of VEGF in the treatment of retarded fetal growth in pregnancy
    Patent number: 8334271
    Abstract: An agonist of the VEGF receptor is useful in the treatment of a disease associated with retarded fetal growth, such as intra-uterine growth retardation. The VEGF agonist may be a VEGF peptide or a gene construct encoding or expressing such a peptide.
    Type: Grant
    Filed: February 22, 2008
    Date of Patent: December 18, 2012
    Assignee: Ark Therapeutics, Ltd.
    Inventors: John Francis Martin, Charles Henry Rodeck
  • Use of VEGF in the Treatment of Retarded Fetal Growth in Pregnancy
    Publication number: 20100249015
    Abstract: An agonist of the VEGF receptor is useful in the treatment of a disease associated with retarded fetal growth, such as intra-uterine growth retardation. The VEGF against may be a VEGF peptide or a gene construct encoding or expressing such a peptide.
    Type: Application
    Filed: February 22, 2008
    Publication date: September 30, 2010
    Inventors: John Francis Martin, Charles Henry Martin, John Francis Martin, Charles Henry Rodeck